Li, Y <br/><br/>
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.  [electronic resource] 

 -  Cancer research  Sep 2001 
 - 6428-36 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Adenovirus E1A Proteins--genetics<br/>Adenovirus E1B Proteins--genetics<br/>Adenovirus E3 Proteins--genetics<br/>Animals<br/>Antibiotics, Antineoplastic--pharmacology<br/>Carcinoma, Hepatocellular--drug therapy<br/>Combined Modality Therapy<br/>Cytopathogenic Effect, Viral<br/>Doxorubicin--pharmacology<br/>Genetic Vectors<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Prostatic Neoplasms--drug therapy<br/>RNA, Messenger--genetics<br/>Response Elements--genetics<br/>Ribosomes--genetics<br/>Tumor Cells, Cultured<br/>Virus Replication<br/>Xenograft Model Antitumor Assays<br/>alpha-Fetoproteins--biosynthesis